Direct the Legislative Research Commission and state agencies to collaborate to create a state fiscal map of substance use disorder programs and funding sources; require the Legislative Research Commission to post the state fiscal map on its website and submit a report to the General Assembly by October 30, 2026.
Create a new section of KRS Chapter 13A to find 201 KAR 9:270 and 201 KAR 20:065 deficient and void; create new sections of KRS Chapters 311, 313, 314, and 315 to establish that the State Board of Medical Licensure, Board of Dentistry, Kentucky Board of Nursing, and Kentucky Board of Pharmacy shall not promulgate administrative regulations that restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the United States Food and Drug Administration for the treatment of a substance use disorder; EMERGENCY.
Create a new section of KRS Chapter 205 to prohibit the Department for Medicaid Services, any Medicaid managed care organization contracted by the department, and the Medicaid state pharmacy benefit manager from denying coverage for a nonopioid analgesic in favor of opioid analgesic or establishing more restrictive or more extensive utilization controls for nonopioid analgesics than the least restrictive or extensive utilization controls for any opioid or narcotic analgesic; require the Cabinet for Health and Family Services or the Department for Medicaid to seek federal approval if it is determined that such approval is necessary; provide authorization from the General Assembly to make changes to the Medicaid program as required under KRS 205.5372(1).
Amend KRS 217.186 to require each public postsecondary educational institution to provide access to opioid antagonists on campus; permit access to be provided by emergency opioid antagonist cabinets; permit application for funds from the opioid abatement trust fund and other available sources to coordinate, maintain, and supply the opioid antagonists; amend KRS 15.291 to add providing access to opioid antagonists on the campuses of public postsecondary educational institutions to the list of projects that may be provided with funding from the opioid abatement trust fund.
Create new sections of KRS Chapter 309 to define terms; establish a licensing board for professional music therapists; require 3 members of the board to have engaged in the practice or teaching of music therapy for at least 3 years; prohibit any persons not licensed by the board from holding himself or herself out as a licensed professional music therapist; authorize the board to promulgate administrative regulations; authorize the board to issue a license to practice music therapy; establish the process for license renewal, suspension, and revocation; establish fees for licensure; establish fee limitations; authorize the board to implement disciplinary actions; require a licensed professional music therapist to collaborate with a client's physician or other professional involved in the treatment of the client; require a licensed professional music therapist to collaborate with a client's mental health or substance use disorder professional involved in the treatment of the client; prohibit a licensed professional music therapist from replacing services provided by an audiologist or a speech-language pathologist; create the Kentucky Board of Licensure for Professional Music Therapists fund; establish a fine for violations; provide for initial board appointments.
Create a new section of KRS Chapter 216B to require each hospital licensed by the Cabinet for Health and Family Services to establish policies and procedures to improve care for sickle cell disease patients, develop programs to prevent and address addiction risks for sickle cell disease patients, and provide patients with education and resources by January 1, 2027.
Amend KRS 304.17A-660 to specify classifications to be included in the term "classification of benefits"; specify requirements, standards, and methodologies to be included in the term "nonquantitative treatment limitation"; change the definition of "mental health condition" to the definition of "mental health or substance use disorder condition"; amend KRS 304.17A-661 to require an insurer's mental health parity analysis to include an evaluation of standards relating to network composition, out-of-network utilization rates, and medical management techniques; require insurers to submit a remediation plan for the commissioner's approval if its mental health parity analysis indicates noncompliance; require insurer's annual mental health parity report to be submitted to the Legislative Research Commission; delete language applying remedies under Subtitle 12 of KRS Chapter 304 to violations; authorize the Attorney General to enforce the mental health parity law; establish duties, remedies, and penalties for enforcement by the Attorney General; authorize a private cause of action by any person directly injured by a violation or likely violation of the mental health parity law; establish duties, remedies, and penalties for a private right of action under the mental health parity law; establish construction clauses; authorize the Attorney General to promulgate administrative regulations for proper enforcement of mental health parity law; create new sections of KRS 304.17A-660 to 304.17A-669 to define "health care professional"; require insurers to comply with KRS 304.17A-700 to 304.17A-730 for claims submitted by health care professionals for the diagnosis or treatment of mental health or substance use disorder conditions; authorize the Attorney General to enforce the requirement to comply with KRS 304.17A-700 to 304.17A-730; create the Advisory Council on Mental Health and Substance Use Disorder Parity; establish duties and membership; amend KRS 304.17A-665 to require the commissioner of insurance to publish a summary of each insurer's mental health parity report and report findings to specified legislative committees; amend KRS 304.17A-669 to conform; amend KRS 18A.225 to require the state employee health plan to comply with KRS 304.17A-660 to 304.17A-669; provide terms for initial appointment of members of the Advisory Council on Mental Health and Substance Use Disorder Parity; provide that certain sections apply to contracts issued or renewed on or after January 1, 2027; EFFECTIVE, January 1, 2027.
Create new sections of KRS Chapter 218A to define terms; establish the ibogaine research and intellectual property fund to be administered by the Department of Agriculture for the purpose of allowing the department to enter a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy; establish requirements for the department related to how it contracts with a drug developer related to ibogaine research and intellectual property; appropriate $21 million from the opioid abatement trust fund to the ibogaine research and intellectual property development fund in fiscal year 2026-2027 and in fiscal year 2027-2028; APPROPRIATION; EMERGENCY.
Create a new section of KRS Chapter 13A to find 201 KAR 9:270 and 201 KAR 20:065 deficient and void; create new sections of KRS Chapters 311, 313, 314, and 315 to establish that the State Board of Medical Licensure, Board of Dentistry, Kentucky Board of Nursing, and Kentucky Board of Pharmacy shall not promulgate administrative regulations that restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the United States Food and Drug Administration for the treatment of a substance use disorder; EMERGENCY.
